ESC 2022 Ashkan Shoamanesh gives a summary of the primary results and exploratory analyses of the phase 2 PACIFIC-STROKE trial with asundexian in patients with non-cardioembolic stroke.
This video was recorded during the ESC Congress 2022 in Barcelona, Spain.
Ashkan Shoamanesh is the Director of the Hemorrhagic Stroke Research Program at the Population Health Research Institute at Hamilton Health Sciences, Hamilton, Canada.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Prof. John Cleland, MD
Prof. Naveed Sattar
Otavio Berwanger, MD, PhD
Prof. Colin Baigent